Relationship between IL-10 gene -819C/T polymorphism and the risk of inflammatory bowel disease: A meta-analysis

African Health Sciences

Volumn 16, Issue 3, 2016, Pages 866-872

  Wu, Haien ^a,b   Guo, Jing Jing ^b   He, Yajun ^a   Yin, Hekun ^b   Shu, Jian Chang ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b JIANGMEN CENTRAL HOSPITAL   (China)

Author keywords

819C T polymorphism; Inflammatory bowel disease; Interleukin 10

Indexed keywords

INTERLEUKIN 10;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; IL 10 GENE; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; RISK; SENSITIVITY ANALYSIS; CHINA; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; ODDS RATIO;

CHINA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 84991794135     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v16i3.30     Document Type: Article

References (26)

1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.
2. Xavier RJ, Podolsky DK.Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434.
3. Zhang H, Ma L, Dong LQ, Shu C, Xu JL. Association of the macrophage migration inhibitory factor gene--173G/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects. Gene 2013;526:228-231.
4. Lee YH, Kim JH, Seo YH, Choi SJ, Ji JD, Song GG.CTLA-4 polymorphisms and susceptibility to inflammatory bowel disease: a meta-analysis. Hum Immunol 2014;75:414-421.
5. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
6. Celik Y, Dagli U, Kiliç MY, et al.Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scand J Gastroenterol 2006;41:559-565.
7. Kuhn R,Lohler J,Rennick D, Rajewsky K,Muller W. In-terleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-274.
8. Menegat JS,Lira-Junior R,Siqueira MA,et al.Cytokine expression in gingival and intestinal tissues of patients with periodontitis and inflammatory bowel disease: An exploratory study. Arch Oral Biol 2016;66:141-146.
9. Yin Q, Zhai Q, Wang D, et al.Investigation on the association between inerleukin-10 -592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy. Int J Clin ExpPathol 2015;8:15216-15221.
10. Eskdale J, Gallagher G, Verweij CL,et al.Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 1998;95:9465-9470.
11. Zhu H, Lei X, Liu Q, Wang Y.Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: a meta-analysis based on 17,585 subjects. Cytokine 2013;61:146-153.
12. Lee YH,Choi SJ,Ji JD,et al.Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to vasculitis: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2012;13:196-201.
13. Egger M, Smith GD, Phillips AN.Meta-analysis: principles and procedures. BMJ 1997;315: 1533-1537.
14. Dupont WD and Plummer WD.Power and Sample Size Calculations for Studies Involving Linear Regression. Controlled Clinical Trials 1998; 19:589-601.
15. Ahirwar DK,Kesarwani P,Singh R,Ghoshal UC,Mittal RD.Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India. J Gastrointest Cancer 2012;43:196-204.
16. Amre DK,Mack DR,Morgan K,et al.The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish casecontrol study. BMC Med Genet 2010;11:82.
17. Fernandez L,Martinez A,Mendoza JL,et al.Interleukin-10 polymorphisms in Spanish patients with IBD. Inflamm Bowel Dis 2005;11:739-743.
18. Sanchez R,Levy E,Costea F,Sinnett D.IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location.World J Gastroenterol 2009;15:3776-3782.
19. Wang AH, Lam WJ,Han DY, et al.The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population. Hum Immunol 2011;72:431-435.
20. Tedde A,Laura Putignano A,Bagnoli S,et al.Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand J Gastroenterol 2008;43:712-718.
21. Andersen V, Ernst A, Christensen J,et al.The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study. BMC Med Genet. 2010;11:82.
22. Haub S,Ritze Y,Bergheim I,Pabst O,Gershon MD,Bischoff SC.Enhancement of intestinal inflammation in mice lacking interleukin-10 by deletion of the serotonin reuptake transporter. Neurogastroenterol Motil 2010;22:826-834.
23. Jafarlou M, Baradaran B, Saedi TA, et al.An overview of the history, applications, advantages, disadvantages and prospects of gene therapy. J Biol Regul Homeost Agents. 2016;30:315-321.
24. Zhang J, Caiyin Q, Feng W, et al.Enhancenisin yield via improving acid-tolerant capability of Lactococcus lactis F44. Sci Rep. 2016;6:27973.
25. Steidler L, Hans W, Schotte L, et al.Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000;289:1352-1355.
26. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Im-munogenet 1997;24:1-8.